Synapse - Anita Kumar

Results (180)

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Targeting CD30 in patients with Hodgkin lymphoma

Book Section

Kumar, A.; Pileri, S.; Younes, A.; Engert, A.
In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

Fulltext@MSK | Save

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era

Journal Article

Kumar, A.; Lunning, M. A.; Zhang, Z.; Migliacci, J. C.; Moskowitz, C. H.; Zelenetz, A. D.
British Journal of Haematology (2015)

Fulltext@MSK | Save

Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial

Meeting Abstract

Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Imaging for staging and response assessment in lymphoma

Journal Article

Johnson, S. A.; Kumar, A.; Matasar, M. J.; Schöder, H.; Rademaker, J.
Radiology (2015)

Fulltext@MSK | Save

Novel agents in mantle cell lymphoma

Journal Article

Kumar, A.
Current Oncology Reports (2015)

Fulltext@MSK | Save

Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma

Journal Article

Mussetti, A.; Kumar, A.; Dahi, P. B.; Perales, M. A.; Sauter, C. S.
Blood Reviews (2015)

Fulltext@MSK | Save

A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma

Journal Article

Kumar, A.; Blum, K. A.; Fung, H. C.; Smith, M. R.; Foster, P. A.; Younes, A.
British Journal of Haematology (2015)

Fulltext@MSK | Save

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study

Journal Article

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Lancet Oncology (2015)

Fulltext@MSK | Save

Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma

Meeting Abstract

Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
Blood (2014)

Fulltext@MSK | Save